HealthcareM&ASanofi said to be considering bid for ActelionDec. 05, 2016 5:04 PM ETSanofi (SNY) StockJNJ, SNYBy: Douglas W. House, SA News Editor11 CommentsBloomberg reports that Sanofi (NASDAQ:SNY) is mulling a bid for Actelion, potentially challenging Johnson & Johnson's (NYSE:JNJ) $250-a-share offer. If so, it will be pricey. Actelion is currently valued at ~$20B.Recommended For YouAbout SNY StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgSNY--SanofiTrending AnalysisTrending News